Ibl Healthcare Limited operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ibl Healthcare Limited with three other
drug stores in Asia:
Meilleure Health International Industry Group Ltd
of Hong Kong
sales of 68.71 million Hong Kong Dollars [US$8.75 million]
of which 63%
was Health Care Related Business),
Kim Forest Enterprise Co Ltd
(264.28 million Taiwanese Dollars [US$8.84 million]
Zenlabs Ethica Ltd
based in India
(811.59 million Indian Rupees [US$11.93 million]
Ibl Healthcare Limited reported sales of 1.19 billion Pakistan Rupees (US$10.29 million)
June of 2017.
increase of 2.9%
versus 2016, when the company's sales were 1.16 billion Pakistan Rupees.
Sales at Ibl Healthcare Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 64%).